Key result
Pharmacist medication reviews in an ambulatory heart failure clinic significantly reduced the average number of drug-related problems per patient compared to no review (1.95 vs 2.55; P=0.016).
Why the study?
The study was conducted to evaluate the impact of pharmacist medication reviews on drug-related problems in an ambulatory heart failure population.
Does a pharmacist medication review service reduce drug-related problems in patients with ambulatory heart failure?
Cohort (n=128)
Does a pharmacist medication review service reduce drug-related problems in patients with ambulatory heart failure?
Pharmacist medication reviews in an ambulatory heart failure clinic significantly reduce drug-related problems.
Answers are grounded in this paper and cite their sources.
Supports pharmacist reviews in ambulatory HF clinics; leaves open effects on clinical outcomes.
Purpose: The purpose of this study was to evaluate the impact of pharmacist medication reviews on drug-related problems (DRPs) in a population with ambulatory heart failure (HF). Methods: The HF pharmacist medication review service incorporated a comprehensive medication review note provided to the cardiologist in a HF clinic. A retrospective chart review was performed on 64 control patients with no previous pharmacist review and 64 intervention patients who had a pharmacist medication review. The primary end point was the number of DRPs identified per patient in the intervention group 2 weeks after pharmacist medication review compared to the number of DRPs identified per patient in the control group. Results: The average DRPs per patient was reduced from 2.80 to 1.95 in intervention group after pharmacist intervention. There was a statistically significant difference between the average DRPs per patient in the control and intervention groups, 2.55 DRPs versus 1.95 DRPs per patient, respectively ( P = .016). Medication adherence (78%), renal dosing (67%), hypertension (58%), and HF DRPs (55%) had the highest acceptance rate. The majority of DRP recommendations in the intervention (87%) and control groups (87%) were high-impact recommendations. Conclusions: Pharmacist medication reviews in an ambulatory HF clinic lead to significantly fewer DRPs.
No takes yet. Share an insight, caveat, or question.
Yates et al. (2019) conducted a cohort in Ambulatory heart failure (HF) (n=128). Pharmacist medication review vs. No previous pharmacist review was evaluated on Number of drug-related problems (DRPs) identified per patient (p=.016). Pharmacist medication reviews in an ambulatory heart failure clinic significantly reduced the average number of drug-related problems per patient compared to no review (1.95 vs 2.55; P=0.016).
Synapse has enriched 10 related papers. Consider them for comparative context: